Fagron NV
F:4A5
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Fagron NV (4A5) under the Base Case is EUR per share.
Compared with the current market price of 24 EUR, the stock appears .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Fagron Does
Fagron NV is a pharmaceutical company focused on compounding, which means making customized medicines for patients whose needs are not met by standard mass-market drugs. It sells raw materials, ready-to-use ingredients, compounding equipment, and prepared formulations that pharmacies, hospital pharmacies, and compounding centers use to make those medicines.
- Headquarters
- Belgium BE
- Employees
- 4 193
- IPO date
- Oct 5, 2007
Fagron has no economic moat
Fagron NV lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysisBalance Sheet
Continue 4A5 Research
Decided on Fagron? Get an email when 4A5 reaches the price you’d buy at. Free with an account.
Other Fagron listings
What is the Intrinsic Value of one 4A5 stock?
The intrinsic value for
Fagron NV (4A5) under the Base Case is EUR.
Is 4A5 stock undervalued or overvalued?
Compared with the current market price of 24 EUR, the stock appears .